S
outh Asia, despite decreasing rates of infectious disease, accounts for a significant proportion of their global burden. The sub-continent is also in the midst of rapid economic growth; large scale changes in land use, access to water and sanitation, and agricultural production; environmental degradation; and technological transformation, all against a background of uneven health system capacity. South Asia, defined by the World Bank as Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka, is home to a quarter of the world's population. Existing infectious disease challenges-including tuberculosis, HIV, and malaria-have been augmented by emerging and growing threats such as dengue, chikungunya, healthcare associated infections, and antimicrobial resistance. These emerging and re-emerging infectious disease challenges threaten to create economic disruption and potentially large morbidity and mortality burdens. Here we review the status, vulnerability, and preparedness for emerging and re-emerging infectious diseases and describe the state of preparedness and surveillance for threats such as Zika, Middle East respiratory syndrome coronavirus (MERS-CoV), and avian influenza.
Although there are frequent reports of sporadic cases of suspected emerging infectious disease syndromes and limited outbreaks of emerging infections such as Nipah virus, Chandipura virus, and Crimean-Congo Haemorrhagic Fever (CCHF), South Asia has not in recent history experienced a large outbreak of an emerging infection. However, factors associated with vulnerability (Table 1) to the emergence of infectious diseases-such as population density, national and international travel, bio-diversity, land use change, zoonotic reservoirs, weak healthcare and public health systems, and deficiencies in water and sanitation-indicate that South Asia is at high risk. Preparedness and the ability to detect and respond to a disease outbreak are critical for national, regional, and global health security.
Current status of emerging and epidemic infections
We have focused on the diseases below as they include the most important emerging and re-emerging illnesses in South Asia. Enteric fever is often diagnosed in patients with fever but is increasingly difficult to treat with fluoroquinolones.
Vector borne viral infections
The main burden of vector borne viral infections in the region is attributable to dengue and chikungunya, while Zika virus is also likely to emerge. Of the 390 million dengue infections that are estimated to occur annually worldwide, over 70% occur in South Asia. 1 Although sporadic cases of dengue infection were seen in many South Asian countries in the 1960s, regular epidemics only occurred in the early 1990s in India and Sri Lanka. 2 Dengue emerged in epidemic proportions in Bangladesh in 2000, 3 in Pakistan in 2006, 4 in Nepal in 2010, 5 and more recently in Bhutan in 2013. 6 In India and Sri Lanka, by around 40 years of age 90% to 95% of adults have been infected with the dengue virus, while 41% have been infected with chikungunya. 2 7 Although the majority of dengue infections are inapparent, the majority of chikungunya infections appear to be symptomatic. 7 In many countries, dengue, which was once a childhood infection, is increasingly seen in adults. 8 The incidence of chikungunya in South Asian countries is lower than dengue and since there is only one serotype, people do not experience repeated infections. 7 Almost all chikungunya infections, however, are symptomatic and some people develop disabling polyarthritis which can last for several months. 9 Co-infection with these two viruses appears to occur often, possibly as both viruses are transmitted by the same vector Aedes aegypti. 9 It is concerning that the Zika virus is also transmitted by the same vector, which is abundant in all South Asian countries. If Zika is introduced to the region it is likely to spread quickly, cause complications in pregnancies, and add to the burden of neurological infections caused by other flavi-viruses such as the West Nile virus and the Japanese Encephalitis virus.
Zoonotic infections
South Asia has been identified as a hot spot for the emergence of zoonotic infectious diseases. 10 11 The endemic zoonoses have re-emerged or emerged in newer areas or with newer clinico-epidemiological presentations, often with more serious manifestations.
Livestock may act as intermediate amplifying hosts, facilitating the transfer of pathogens from their normal ecological niche into humans. Examples are Japanese encephalitis (JE), Nipah virus, and Crimean-Congo haemorrhagic fever (CCHF). JE has spread to newer areas in the subcontinent against a backdrop of a large proportion of undiagnosed cases of acute encephalitis syndrome. 12 JE has become endemic to the Kathmandu valley region after its introduction in early 2000. 13 Nipah virus emerged in Malaysia in the late 1990's, initially being misdiagnosed as JE, and there have since been frequent outbreaks in Bangladesh and, to a lesser extent, India. CCHF has recently been recognised in humans in South Asia for the first time. 14 15 The highly pathogenic avian influenza (HPAI) virus A/H5N1, which was introduced to the subcontinent in 2005 through wild birds, has since become endemic across large parts of north east India and Bangladesh, across porous international borders.
Key MeSSageS:
• South Asia accounts for a significant proportion of the global burden of infection diseases, although in recent history it has not experienced a large outbreak of an emerging infection.
• The region remains seriously vulnerable to existing and new threats including Zika, Ebola, MERS-CoV, and avian influenza.
• Surveillance and preparedness for early detection of outbreaks is crucial in this region inhabited by one fourth of the world's population.
It has resulted in losses of around US$500 million (£398m; €460m). [16] [17] [18] Rates of neuroleptospirosis and leptospirosis have been rising in north India and Sri Lanka and have been associated with disseminated intravascular coagulation. 19 20 The growing proportion of severe cases of leptospirosis has created massive pressures on the healthcare delivery systems in affected countries. 21 Scrub typhus, which has been grossly under reported in South East Asian countries, 22 is now increasingly being seen in newer ecological niches such as urban landscapes. [23] [24] [25] Anthrax is endemic in large parts of South Asia. In the border areas of India, Bangladesh, and Myanmar, poor vaccination and surveillance have been accompanied by increasing anthrax cases, which prompted Bangladesh to announce a "red alert" in 2010. 26 Rabies remains endemic in eight countries in South East Asia, with 1.4 billion people at risk. The region contributes about 45% of global rabies deaths, while the rhetoric on elimination continues to grow. 27 28 Brucellosis, bovine tuberculosis, and a range of food borne diseases contribute to the morbidity and mortality attributable to zoonotic infections but are struggling to gain the attention of policy makers in the subcontinent, 29 30 despite resulting in 150 million illnesses, 175 000 deaths, and 12 million disability adjusted life years. 31 Enteric fever and antimicrobial resistance Enteric (typhoid) fever is caused by bacteria Salmonella typhi and Salmonella paratyphi. 32 S typhi is the most common bacterial organism grown in blood cultures in South Asia. These organisms cause indistinguishable clinical features that generally comprise of high fever for at least 3 days with no localising signs. 33 Typhoid fever is one of the most common diagnoses in cases of fever in the region. Blood cultures (the gold standard for the diagnosis of typhoid fever) are not readily available in most, especially rural, regions of South Asia. Instead the widely available Widal test, a slide agglutination test developed in 1896, is often used to make a definitive diagnosis of enteric fever. 34 Unfortunately, it is difficult to establish a "cut off" for this test. The test also cross reacts with malaria parasites, rickettsial organisms, and dengue virus, all very common causes of undifferentiated febrile illness in South Asia.
The use of the Widal test has sometimes had dire consequences, such as when outbreaks of scrub typhus in Nepal were mistakenly diagnosed as enteric fever and suboptimal treatment with ceftriaxone administered. 35 36 Finally, even where blood culture facilities are available, because of the paucity of the typhoid organism in the blood, blood culture growth is usually restricted to about 50%. So without proper diagnostics, it is hard not only to prescribe appropriate treatment but also to estimate the true burden of typhoid fever in South Asia.
In recent years, the appearance in South Asia of fluoroquinolone resistant H 58 typhoid organisms has made the treatment of this disease even more challenging. 37 
Polio
The elimination of polio from many countries in the region, most recently in India, is a landmark achievement. However, two out of the three remaining countries in the world with endemic polio are in South Asia. There were only 74 wild type polio cases in Pakistan and Afghanistan in 2015, and 33 in 2016. However, unrest in these countries threatens progress in eradication and is a high priority for regional cooperation.
Vulnerabilities of South Asia
South Asia already has some of the most densely populated areas in the world and is projected to see rapid shifts in urbanisation, population density, dietary patterns, and subsequent demand for animal source foods and agriculture intensification-all of which are considered important drivers of zoonoses. 38 While these factors are also indicators of economic growth, human and animal healthcare systems have failed to keep pace with the corresponding need for sectoral and intersectoral surveillance and coordination. 39 Institutional capacity for epidemiological and laboratory response, especially at sub-national levels, remains limited, more so in veterinary sectors. Surveillance systems often are incomplete in their reach, fail to identify early warning signals, and communicate poorly across sectors. Despite the visibility following emergence of HPAI, limited capacity and infrastructure has kept wildlife departments in most countries from being active participants in preparedness and response efforts.
The outbreak of MERS-CoV in South Korea in 2015 served as a warning about the vulnerability to infectious disease outbreaks of overstretched, crowded, and unprepared healthcare systems. 40 Healthcare systems The rate of land use change in most of South Asia is now slow. Where land can be agriculturalised it has been, and much of the land is already extensively cropped. The rate of forest growth is positive in India, there being net reforestation.
Changes in land use may alter ecosystems and the interaction of animal hosts with humans, giving rise to new opportunities for amplification and / or spill over to humans 56 Biodiversity 57 South Asia is not especially bio-diverse but India may be a hot spot of bat to human virus sharing 58 The impact of declining biodiversity is variable, and may act to either increase or decrease the emergence of infectious diseases 57 Insect and tick vectors 59 Mosquito and tick vectors are widely present for some serious infections 60 -62 As Zika virus has shown, the presence of competent vectors can lead to dramatic introductions and transmission of pathogens Livestock density
Cattle and goats are raised in large numbers across South Asia. As incomes increase the demand for meat will increase and livestock farming will intensify Livestock may act as intermediate hosts for a range of zoonotic infections including CCHF, fascioliasis, bovine TB, brucellosis, and leptospirosis from cattle; and fascioliasis, brucellosis, Orf virus, and Q fever from sheep. Rift Valley fever could be introduced successfully to South Asia 63 Poverty and human development index South Asia has had a period of sustained economic growth, declining poverty rates, and improved human development. Nevertheless the region is home to a very large number of poor people with poor infrastructure Poverty is a risk factor for almost every infection, but is a particular vulnerability for epidemic infections. Poverty is associated with crowding, poor sanitation, poor nutrition, and poor access to preventive, diagnostic, and therapeutic healthcare. It is no coincidence that Ebola raged out of control in three of the poorest countries in Africa Healthcare systems
The public healthcare systems in South Asia are poor, with patchy coverage, limited resources, overcrowding, and inadequate infrastructure
Healthcare systems can contribute to the emergence and transmission of infectious diseases in several ways:
• Resistance to antibacterial, antiviral, and anti-malarial drugs can be promoted by poor use of these drugs • Healthcare settings can amplify infections. The introduction and transmission of MERS-CoV in Korea is a good example are variable, but in South Asia there are the substantial challenges of inadequate infrastructure, poor quality services, fragmented health information systems, and weak controls over the private healthcare sector. 41 This poses a risk of the late detection, and potentially explosive amplification, of epidemic prone infections within the healthcare system. Fundamentally, the current state of affairs in the subcontinent flows from severe policy neglect. The One Health initiative is a worldwide, cross-sector approach to addressing vector borne and zoonotic diseases. While the world has moved towards incorporating One Health in their policy discourse, South Asia has been slow to adopt this approach, except for initial signs in Bangladesh. 42 There have been limited efforts to build One Health capacity in the subcontinent, initiated mostly by external agencies, 43 but policymakers remain disengaged in the absence of a convincing case made by the research community. 44 45 This disconnect is further exemplified by the fact that veterinary research has focused more on increasing animal productivity, while neglecting zoonotic potential. 46 The trepidations experienced during the outbreaks of Ebola in West Africa and subsequently during Zika cases in South America is justified given the fact that, if a rapidly spreading infection finds its way into South Asia, it could wreak havoc before being brought under control. 47 
Preparedness
There is limited regional capacity to identify, respond to, and mitigate emerging infectious disease threats in South Asia. The main reason seems to be a lack of political will. While mechanisms for regional collective conversations do exist, they have not translated into the kind of operational capabilities that the European Centers for Disease Prevention and Control or the European Commission are able to facilitate within the European Union. Moreover, the composition of the World Health Organization's South East Asia Regional Office leaves out key countries (Afghanistan and Pakistan) in the region, hindering cooperation at WHO level.
Clearly civil societies and research communities in the region need to work together to tackle these risks and vulnerabilities and to lobby for more political commitment. Multiple approaches need to be considered to overcome the limited preparedness of the region. 48 Regional cooperative surveillance programmes, such as those promoted by the Connecting Organizations for Regional Surveillance (CORDS) initiative, may strengthen regional surveillance and preparedness. The South Asian Association for Regional Cooperation (SAARC) should be activated and work alongside inter-governmental agencies such as WHO, the Food and Agriculture Organization of the United Nations, and the World Organization for Animal Health.
The European Commission and the European Developing Countries Clinical Trials Partnership (EDCTP) have supported the establishment of regional clinical research networks for emerging and epidemic prone infectious diseases in Europe, Latin America, and Africa. A major regional funding initiative is needed to establish a similar, sister clinical research network in South Asia that can tackle the combined threats of antimicrobial resistance and epidemic prone infections. However, especially in the context of South Asia, public health research, including systems and policy research, should not take a back seat to clinical research.
The fragmentation of prevention measures and the need to break the traditional governance silos of human and animal health systems is a significant challenge. Facets of the response may include establishing harmonised international commitments to enforce minimal assurances to confront zoonoses 49 ; establishing effective intersectoral coordination measures without adversely reducing the core competencies of participating agencies; devising acceptable, effective, and sustainable policies, including trade laws, that tackle risks without endangering livelihoods; and investment in human and animal healthcare capacity at individual (caregivers) and systems (infrastructure) levels.
At the global scale, South Asia must become more engaged in the health security agenda. The government of India is a founder contributor to the Coalition for Epidemic Preparedness Innovation (CEPI), an initiative that aims to accelerate the development of new vaccines for high threat pathogens. This leadership is commendable, but such research and development pipelines needs to be linked to strengthened surveillance, response, and research platforms within South Asia to ensure that it can be evaluated and implemented locally. Finally, global science communities can help enhance regional conversation to encourage local collaboration.
Tackling these systemic shortcomings needs a concerted approach that takes a medium to long term view of outcomes. Focus should be on building strong, intersectorally connected systems, with aligned policies driven by One Health, as institutions come together to review programmes and policies.
Outlook
Early detection of outbreaks is crucial for their early control. Mathematical models have suggested that it might be possible to contain an emerging pandemic of avian influenza if detection and reporting of cases that suggest human to human transmission happen within around three weeks of the first case. 50 51 A report in 2010 of 398 WHO notified outbreaks that happened between 1996 and 2009 found that only 7% occurred in the WHO South East Asia region and that, over the period studied, the timeliness of detection had improved, although significant delays in public notification remained. 52 A 2016 update has not changed the overall picture. 53 This implies that outbreaks in South Asia are less common than elsewhere, since the WHO South East Asia region has around 27% of the world population yet only 7% of reported outbreaks. This is surprising given that the characteristics of South Asia show its vulnerability to emerging and epidemic infections. We must not ignore this warning that outbreaks are less well detected and reported in this region.
The revised International Health Regulations (IHR) whose aim is to help the international community prevent and respond to acute public health risks that can cross borders was implemented in 2007. They appear to have had a positive effect on detection and reporting, and the latest data on IHR core capacities (2013) shows good levels in South East Asia. 52 54 This indicated that the region is well prepared. However the core capacity indicators have been criticised. 55 Clearly, there has been insufficient work on epidemic preparedness in South Asia. Unless immediate attention is given to preparedness and ability to respond, the region remains vulnerable to existing and new threats including Zika, Nipah, MERS-CoV, and avian influenza.
